HLA-C and myeloid sarcoma: Patients with MS with HLA-DRB1*15 or HLA-B*07 alleles have elevated EBV viral loads, while those with HLA-A*02 have lower viral loads22, suggesting that both class I and class II MHC molecules may influence EBV latency control.